Variable | Percentage | N |
Health outcomes | ||
Specific health outcome | 57 | 137 |
General health outcome | 36 | 85 |
Hybrid | 5 | 11 |
Not applicable | 3 | 6 |
Risk type | ||
Self | 48 | 114 |
Specific other | 8 | 19 |
Average other | <1 | 1 |
General | 42 | 100 |
Not applicable | 2 | 5 |
Absolute or comparative | ||
Absolute | 75 | 179 |
Comparative | 22 | 52 |
Not applicable | 3 | 8 |
Conditional | ||
Product* | 54 | 129 |
Time | 1 | 3 |
Other | 1 | 3 |
Frequency and product | 8 | 19 |
Time and product | 2 | 5 |
Frequency, time and product | 5 | 12 |
Product and other | 1 | 2 |
Unknown/not applicable | <1 | 1 |
Not assessed | 27 | 65 |
Severity | 11 | 27 |
Affect | 9 | 22 |
Controllability | 8 | 19 |
Risks known to experts or others | 3 | 8 |
Numeric risk estimate | 6 | 15 |
Rating scale (Likert type) | 77 | 183 |
Other response option | 17 | 41 |
Transformation/combination of items | 12 | 28 |
*Sixty-two per cent (n=148) of all items coded assessed the risk associated with cigarette smoking, and 26% did not include a product (eg, “How likely are you to get lung cancer?”). The remaining items assessed the risk of hookah smoking (n=12, 5%); menthol cigarettes (n=5, 2%); e-cigarettes (n=3, 1%); bidis (n=3, 1%); roll-your-own, pipes and cigars (n=3, 1%); reduced-risk-labelled cigarettes (n=2, 0.8%); or general tobacco (n=1, 0.4%) (data not shown). In some instances, both cigarettes and other products were assessed together (n=12, 5% eg, “How do you compare Shisha and cigarette smoking considering their health effects?”).